Pancreatic Cancer Research

ResearcherUniversité Toulouse III - Paul SabatierActive in the last 2 years

Cindy Canivet

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-5533-0494; OpenAlex author ID A5087509645. Sources: OpenAlex.

Their work

Papers
13 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 4 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers · 2026: 1 paper

Papers 13

  1. Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project. Co-author DOI 10.1093/ije/dyag064↗
  2. Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study. First author DOI 10.1016/j.esmogo.2025.100144↗
  3. Risk Assessment Models for Predicting Venous Thromboembolism in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers17040597↗
  4. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prosp… First author DOI 10.1016/j.ebiom.2024.105373↗
  5. Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients. First author DOI 10.1038/s41598-024-76903-y↗
  6. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project. Co-author DOI 10.1186/s12885-024-12463-8↗
  7. Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-22-946↗
  8. Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy. Last author DOI 10.1055/a-1799-7774↗
  9. Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2020.102858↗
  10. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. Co-author DOI 10.1053/j.gastro.2019.12.009↗
  11. A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score. First author DOI 10.3390/cancers12040783↗
  12. Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Tria… Co-author DOI 10.3390/cancers12082028↗
  13. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort. Co-author DOI 10.1186/s12885-018-4906-4↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Barbara Bournet · 10 shared papers, 2018–2026 · strength 1.45
  2. Louis Buscail · 8 shared papers, 2018–2026 · strength 1.13
  3. Fabrice Muscari · 3 shared papers, 2020–2024 · strength 0.47
  4. Dominique Farge Bancel · 3 shared papers, 2018–2025 · strength 0.42
  5. Corinne Frère · 2 shared papers, 2020–2025 · strength 0.36
  6. Bertrand Napoléon · 3 shared papers, 2018–2022 · strength 0.31
  7. Charlotte Maulat · 2 shared papers, 2020–2024 · strength 0.28
  8. Serena Oliveri · 1 shared paper, 2026 · strength 0.21
  9. Lorenzo Gervaso · 1 shared paper, 2026 · strength 0.21
  10. Mireia Obón‐Santacana · 1 shared paper, 2026 · strength 0.21
  11. Lois Riobó‐Mayo · 1 shared paper, 2026 · strength 0.21
  12. Nicola Fazio · 1 shared paper, 2026 · strength 0.21
  13. Victor Rau Moreno · 1 shared paper, 2026 · strength 0.21
  14. Jerome F. Cros · 2 shared papers, 2020–2023 · strength 0.20
  15. Bruno Costa‐Silva · 1 shared paper, 2024 · strength 0.19
  16. Thomas Bardol · 1 shared paper, 2024 · strength 0.19
  17. Catherine Alix‐Panabières · 1 shared paper, 2024 · strength 0.19
  18. Emmanuel Cuellar · 1 shared paper, 2024 · strength 0.18
  19. Naïma Hanoun · 1 shared paper, 2024 · strength 0.18
  20. Pierre Cordelier · 1 shared paper, 2024 · strength 0.18
  21. Stéphanie Truant · 2 shared papers, 2018–2020 · strength 0.16
  22. Eric Assénat · 2 shared papers, 2018–2020 · strength 0.16
  23. Sylvain Manfrédi · 1 shared paper, 2023 · strength 0.12
  24. Côme Lepage · 1 shared paper, 2023 · strength 0.12
  25. Noelle K. LoConte · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.